Zdrowie i gospodarka · 27/02/2023
FDA Clears CHANTIX Tablets for Sale Despite Nitrosamine Concerns
The FDA has determined that CHANTIX tablets, 0.5mg and 1mg, can be manufactured without exceeding acceptable nitrosamine impurity limits, allowing the drug to remain on the market.
Source: Federal Register — Food and Drug AdministrationOpen original release →